Brief: Medigene submits CTA for its first TCR clinical trial

Medigene AG

10/07/2017 14:35

July 10 (Reuters) - MEDIGENE AG  MDG1k.DE  
    * PTA-ADHOC: MEDIGENE AG: MEDIGENE SUBMITS CTA FOR ITS FIRST 
TCR CLINICAL TRIAL AND ANNOUNCES MILESTONE PAYMENT 
    * EXPECTS TO START THIS TRIAL BY YEAR END 2017 
    * SUBMISSION TRIGGERS FINAL MILESTONE PAYMENT OF EUR 2.0 
MILLION FROM MEDIGENE TO FORMER CONTRIBUTING SHAREHOLDERS OF 
MEDIGENE IMMUNOTHERAPIES GMBH WITHIN NEXT FIVE MONTHS 
    * INTENDS TO SETTLE THIS PAYMENT THROUGH ISSUANCE OF NEW 
SHARES FROM AUTHORIZED CAPITAL 
 
Source text for Eikon:  ID:nPexTvQRGa  
Further company coverage:  MDG1k.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))